[Biological therapy of inflammatory bowel disease]

Autor:	L B, Lazebnik, A I, Parfenov, O V, Kniazev, A G, Konopliannikov, V E, Sagynbaeva, M V, Iakovleva, T A, Astrelina, I N, Ruchkina, P L, Shcherbakov, I E, Trubitsyna, T M, Tsaregorodtseva, R B, Gudkova, V A, Rogozina, B Z, Chikunova, S G, Khomeriki, Z F, Mikhaĭlova
Rok vydání:	2011
Předmět:	Treatment Outcome Chronic Disease Anti-Inflammatory Agents Antibodies Monoclonal Humans Drug Therapy Combination Inflammatory Bowel Diseases Mesenchymal Stem Cell Transplantation Combined Modality Therapy Infliximab
Zdroj:	Eksperimental'naia i klinicheskaia gastroenterologiia = Experimentalclinical gastroenterology. (2)
ISSN:	1682-8658
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=pmid________::a96c699af46662e9cad43086d417df6d https://pubmed.ncbi.nlm.nih.gov/21560638 Zobrazit plný text záznamu